Please assess the completion status of the following clinical trial:

Trial Title: Mifepristone for Labor Induction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Pregnant patients between ages 18 to 45 years~2. Singleton, live gestation~3. Nulliparous~4. Gestational age between 37 weeks 0 days - 42 weeks 0 days~5. Fetus in cephalic presentation~6. Patients admitted for labor induction~7. Patients who are not in labor with intact membranes~8. Patients with no contraindication for vaginal delivery (placenta previa, vasa previa, active genital herpes)~9. Patients with no contraindications for mifepristone (chronic adrenal failure, concurrent long-term corticosteroid therapy, history of allergy to mifepristone, or other prostaglandins, hemorrhagic disorders or concurrent anticoagulant therapy, inherited porphyria, or an intrauterine device (IUD) in place)~10. Patients with a Bishop score \<6 at time of randomization~11. Transcervical balloon in place \<3 hours prior to the time of randomization without prior cervical preparation~Exclusion Criteria:~1. Significant cardiac, renal, or hepatic maternal comorbidities, severe gestational hypertension or preeclampsia with severe features~2. Pregnancies complicated by major fetal anomalies~3. Patients with a uterine scar~4. Pregnancies complicated by fetal growth restriction (Estimated fetal weight \<10%)~5. Pregnancies complicated by oligohydramnios~6. Fetuses with an estimated fetal weight \>4500 gm by recent ultrasound or Leopold's exam on admission~7. Patients with class 3 obesity (BMI \>40)~8. Fetuses with a persistent category 2 or 3 fetal heart tracing at labor induction admission~9. Vaginal bleeding at the time of randomization~10. Any indication for scheduled cesarean delivery~11. Hypersensitivity to oxytocin~12. Uterine contractions equal to or greater than 5 in 10 minutes for sustained 30 minutes~13. Hypersensitivity to prostaglandins

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Mifepristone (Type: ACTIVE_COMPARATOR): Participants will be given mifepristone with insertion of the cervical Cook balloon for labor induction
- Misoprostol (Type: ACTIVE_COMPARATOR): Participants will be given misoprostol with insertion of the cervical Cook balloon for labor induction

Based on this trial design, predict the completion outcome and termination type (if applicable).